Home » Stocks » CLPT

ClearPoint Neuro Inc. (CLPT)

Stock Price: $17.50 USD 1.74 (11.04%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
After-hours: $18.75 +1.25 (7.14%) Jan 15, 7:53 PM
Market Cap 295.22M
Revenue (ttm) 12.32M
Net Income (ttm) -6.85M
Shares Out 15.72M
EPS (ttm) -0.43
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $17.50
Previous Close $15.76
Change ($) 1.74
Change (%) 11.04%
Day's Open 16.69
Day's Range 15.30 - 17.99
Day's Volume 451,971
52-Week Range 3.08 - 17.99

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 1 day ago

IRVINE, Calif., Jan. 14, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today report...

GlobeNewsWire - 3 days ago

IRVINE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the bra...

GlobeNewsWire - 2 weeks ago

Represents Draw of Additional Proceeds from Petrichor Announced in January 2020 Represents Draw of Additional Proceeds from Petrichor Announced in January 2020

GlobeNewsWire - 1 month ago

IRVINE, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), a leader in image-guided stereotactic neurosurgery, announced that its 4,000th neurosurgical procedure ...

GlobeNewsWire - 2 months ago

IRVINE, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), a medical device company with a portfolio of products focused on enabling therapies for neurological di...

About CLPT

ClearPoint Neuro operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system, a neuro-navigation system designed for insertion of catheters, electrodes, and laser fibers to treat various neurological diseases and conditions, as well as for performing biopsies. In addition, the company's product pipeline inc... [Read more...]

Industry
Medical Devices
Founded
1998
Stock Exchange
NASDAQ
Ticker Symbol
CLPT
Full Company Profile

Financial Performance

In 2019, CLPT's revenue was $11.22 million, an increase of 52.54% compared to the previous year's $7.35 million. Losses were -$5.54 million, -10.12% less than in 2018.

Financial Statements

Analyst Forecasts

According to one analyst, the rating for CLPT stock is "Strong Buy" and the 12-month stock price forecast is 18.00.

Price Target
$18.00
Analyst Consensus: Strong Buy